Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04960618
Title Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sezary Syndrome
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) RECRUITING Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) RECRUITING Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Bergen (Limited Protocol Activities) RECRUITING Montvale New Jersey 07645 United States Details
Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) RECRUITING Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester (Limited Protocol Activities) RECRUITING Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center (All protocol activities) RECRUITING New York New York 10021 United States Details
Columbia University RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Nassau (Limited protocol activities) RECRUITING Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field